Nov 9, 2007

New Cancer Therapies for Animal Companions

ENTIRE CATALOG OF FERRET PROTEINS TO DATE


In reading one of my several complimentary pet therapies books I came across a therapy for cancer treatment I have never heard about. It translates to "activated lymphocyte therapy". ( 活性化リンパ球療法 )

It seems to be more well-known and accepted here in Japan, but it mostly seems experimental in the US. (You can search for that term in the clinical trails DB and then also choose "include trials that are no longer recruiting patients." to get more results. )

Here is a brief explanation in English from a Japanese company currently engaged in that research if you have never heard of it.

My question is has anyone heard of it used on pets in the US? The book by Chief Veterinarian at NORIKO Animal Hospital Dr. Noriko Miyano implies that it is being used as a treatment option here in Japan. She does not go into detail though because the book's actual focus is on Chinese medicine usage in pets.

Thank you.

Thanks for stopping in! We hope you'll be back!

Ads make the world go around. Help us out!

Labels: ,

Sep 11, 2007

Animal Chip Implants Linked to Cancer

ENTIRE CATALOG OF FERRET PROTEINS TO DATE


Even though this is only a preliminary study not definitive, I find this both concerning and disappointing. Concerning because cancer has been such an oppressive enemy for so long, disappointing in that yet again a government official is playing both sides. To top it off, I have heard many cities in the US are now making micro-chipping MANDATORY for pets. And previous to that, many people just jumped on board because of how useful it would be if their animal companions got lost or stolen.

I wonder (and worry) if eventually they will not find a similar problem in the melatonin chips that are wildly popular with ferret folk?



This weekend the Associated Press broke a story suggesting a link between VeriChip's implantable chip technology in animals and the formation of cancerous tumors. The story has been picked up widely, from the mainstream media to tech blogs to pet publications. Following is what the RFID industry needs to know.

From 1996 to 2006, a handful of studies reported incidences of tumors in lab mice and rats that had been implanted with chips. Specifically, malignant tumors (sarcomas) developed near and around the chips, in some cases completely enveloping them. A 1998 study in the US found the incidence of cancer to be higher than 10 percent in a group of 177 tested mice. A 1997 German study revealed a cancer incidence of one percent in a group of over four thousand, with the researchers noting that the tumors "are clearly due to the implanted microchips." And just last year a study in France saw 4.1 percent of 1,260 chipped mice develop cancer.

The significance of these findings is not just the potential danger to chipped pets, but the fact that the technology in question is essentially the same as that used in the VeriChip product for humans.

Note, however, that the findings are preliminary and do not definitively condemn the technology as a cause of cancer in animals or in humans. One study said as much, cautioning, "Blind leaps from the detection of tumors to the prediction of human health risk should be avoided." Ohio State University veterinarian oncologist Dr. Cheryl London commented, "It's much easier to cause cancer in mice than it is in people. So it may be that what you're seeing in mice represents an exaggerated phenomenon of what may occur in people." Perhaps most significant of all is the fact that millions of pets have been chipped over the last fifteen years, and no widespread problem has surfaced. (Although after the attention this story will bring, new cases might well be uncovered.)

Still, the studies warrant further investigation, according to a number of cancer researchers whom the AP asked to review and interpret the research. Dr. Robert Benezra, head of the Cancer Biology Genetics Program at the Memorial Sloan-Kettering Cancer Center in New York, told the AP, "There's no way in the world, having read this information, that I would have one of those chips implanted in my skin, or in one of my family members." Others were less dramatic. National Cancer Institute veterinary oncologist Dr. Chand Khanna acknowledged that the studies "suggest some reason to be concerned about tumor formations" and advocated further investigation. Forensic pathologist Dr. Oded Foreman of the Jackson Laboratory in Maine said that there "might be a little hint that something real is happening here."

One curious wrinkle to the story is how the studies have gone relatively unnoticed, even by VeriChip itself...

Read The Full Story Here


Thanks for stopping in! We hope you'll be back!

Ads make the world go around. Help us out!

Labels: , , ,

Jan 27, 2007

2007 week 05: Articles of Related Interest

ENTIRE CATALOG OF FERRET PROTEINS TO DATE


Chopping Off Protein Puts Immune Cells Into High Gear
The complex task of launching a well-organized, effective immune system attack on specific targets is thrown into high gear when either of two specific enzymes chop a protein called LAG-3 off the immune cells leading that battle, according to investigators at St. Jude Children's Research Hospital.

Role For Proteomics In Identifying Hematologic Malignancies
Scientists have identified a set of biomarkers that could help clinicians identify a group of hematologic malignancies known as myelodysplastic syndromes (MDS), which affect approximately 300,000 individuals worldwide and often progress to acute myeloid leukemia.

Motor protein plays key role in connecting neurons
A motor protein called myosin X runs the main road of a developing neuron, delivering to its tip a receptor that enables it to communicate with other neurons, scientists say. In another piece of the puzzle of how neurons form connections, researchers have found myosin X travels a portion of a neuron's backbone called the actin filament, a sort of two-way highway in the cell's highest traffic area, says Dr. Wen-Cheng Xiong, developmental neurobiologist at the Medical College of Georgia.

'Quiet Revolution' May Herald New RNA Therapeutics
Scientists at the University of Oxford have identified a surprising way of switching off a gene involved in cell division. The mechanism involves a form of RNA, a chemical found in cell nuclei, whose role was previously unknown, and could have implications for preventing the growth of tumour cells.
RNA plays an important and direct role in the synthesis of proteins, the building blocks of our bodies. However, scientists have known for some time that not all types of RNA are directly involved in protein synthesis. Now, in research funded by the Wellcome Trust and the Medical Research Council, a team of scientists has shown that one particular type of RNA plays a key role in regulating the gene implicated in control of tumour growth. The research is published online today in Nature.

Chemical Switch Triggers Critical Cell Activities
The freeze-frame image of a molecular relay race, in which one enzyme passes off a protein like a baton to another enzyme, has solved a key mystery to how cells control some vital functions, according to investigators at St. Jude Children's Research Hospital. A report on this work appears in the January 14 advanced online publication issue of Nature.

Buckyballs used as 'passkey' into cancer cells
Rice University chemists and Baylor College of Medicine pediatric scientists have discovered how to use buckyballs as passkeys that allows drugs to enter cancer cells. Research in the January 21 issue of the journal Organic and Biomolecular Chemistry, describes how the researchers mimicked the techniques used by some viruses to introduce non-toxic bits of buckyball-containing protein into both neuroblastoma and liver cancer cells.

Filamins Tether Cystic Fibrosis Protein To Cell Surface
Cystic fibrosis (CF) is caused by mutations in a gene that encodes a protein known as CFTR. More than 1000 different disease-causing mutations in CFTR have been identified, and although the overall effect of each mutation is to decrease CFTR expression at the cell surface, it is not known for every one of these mutations what the molecular defect is that causes the decreased cell surface expression of CFTR.
From the article itself: "Our data demonstrate what we believe to be a previously unrecognized role for the CFTR N terminus in the regulation of the plasma membrane stability and metabolic stability of CFTR. In addition, we elucidate the molecular defect associated with the S13F mutation."

Breakthrough Could Prevent Multiple Fibrotic Diseases: Tests Find Protein Stops Fibrosis In Lung, Heart, Other Tissues Science Daily
A scientific breakthrough at Rice University could lead to the first treatment that prevents the build-up of deadly scar tissue in a broad class of diseases that account for an estimated 45 percent of U.S. deaths each year.
"Fibrotic diseases kill so many people because they can crop up in almost any part of the body, and cardiac fibrosis is a particular problem for anyone who's had a heart attack," said Richard Gomer, professor of biochemistry and cell biology at Rice. "We've discovered a naturally occurring blood protein that prevents dangerous scar tissue from forming."

Brown team finds crucial protein role in deadly prion spread
Brown University biologists have made another major advance toward understanding the deadly work of prions, the culprits behind fatal brain diseases such as mad cow and their human counterparts. In new work published online in PLoS Biology, researchers show that the protein Hsp104 must be present and active for prions to multiply and cause disease.

Scripps Research study reveals new function of protein kinase pathway in tumor suppression
Scientists at the Scripps Research Institute have discovered a surprising new function of a well-known signaling pathway that, when activated, can inhibit tumor development. This finding may lead to the development of drugs that can serve as an effective cancer therapy by artificially activating this pathway in cancer cells.

Disabling key protein may give physicians time to treat pneumonic plague
The deadly attack of the bacterium that causes pneumonic plague is significantly slowed when it can't make use of a key protein, scientists at Washington University School of Medicine in St. Louis report in this week's issue of Science.

Thanks for stopping in! We hope you'll be back!

Ads make the world go around. Help us out!

Labels: , , , , , , , , , , ,

Jan 3, 2007

2007 week 01: Articles in Veterinary Science

ENTIRE CATALOG OF FERRET PROTEINS TO DATE


Isolation of ferret protein promising for cancer, reproductive studies
Although the focus of the study was about pregnancy, there was this interesting general finding.
Clip:
The protein -- glucose-6-phosphate isomerase (GPI) -- already is widely known as a highly conserved enzyme occurring in intracellular metabolism, converting sugars in glycolysis in many organisms and humans. "In the domestic ferrets that we studied, we found a unique role for this enzyme as a secreted protein that is essential in the reproductive process," Bahr said. "Interestingly, he same ability to secrete this protein is found in many types of metastatic tumors, suggesting that tumor cells have co-opted this process. The secretion of GPI allows the tumors to find and lock onto receptors to invade healthy tissues." The ability of tumors to spread is similar to the invasive process of implantation.

Thanks for stopping in! We hope you'll be back!

Ads make the world go around. Help us out!

Labels: , , ,